Expression of ERV3-1 in Leukocytes of Acute Myelogenous Leukemia Patients.

[1]  M. Dawson,et al.  Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia , 2020, Nature Communications.

[2]  Geo Pertea,et al.  Transcriptome assembly from long-read RNA-seq alignments with StringTie2 , 2019, Genome Biology.

[3]  T. Imanishi,et al.  Comprehensive genomic analysis reveals dynamic evolution of endogenous retroviruses that code for retroviral-like protein domains , 2019, Mobile DNA.

[4]  S. Salzberg,et al.  CHESS: a new human gene catalog curated from thousands of large-scale RNA sequencing experiments reveals extensive transcriptional noise , 2018, Genome Biology.

[5]  Hang Zheng,et al.  PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression , 2018, Cancer Cell International.

[6]  J. Cortes,et al.  Acute myeloid leukaemia , 2018, The Lancet.

[7]  S. Gill,et al.  Novel Approaches to Acute Myeloid Leukemia Immunotherapy , 2018, Clinical Cancer Research.

[8]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[9]  T. Imanishi,et al.  Systematic survey of non-retroviral virus-like elements in eukaryotic genomes. , 2018, Virus research.

[10]  J. Briggs,et al.  The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer , 2018, Cell.

[11]  Jeremy Stinson,et al.  Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia , 2017, The Journal of cell biology.

[12]  F. Fagioli,et al.  Expression of the pol gene of human endogenous retroviruses HERV-K and -W in leukemia patients , 2017, Archives of Virology.

[13]  R. Rosell,et al.  Human endogenous retroviruses and cancer , 2016, Cancer biology & medicine.

[14]  K. Imakawa,et al.  Baton pass hypothesis: successive incorporation of unconserved endogenous retroviral genes for placentation during mammalian evolution , 2015, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  Yung-Hyun Choi,et al.  Elevation of human ERV3-1 env protein expression in colorectal cancer , 2014, Journal of Clinical Pathology.

[16]  X. Xu,et al.  The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells , 2013, Leukemia.

[17]  J. Meyers,et al.  Medicare Fee-for-Service Enrollees with Primary Acute Myeloid Leukemia: An Analysis of Treatment Patterns, Survival, and Healthcare Resource Utilization and Costs , 2013, Applied Health Economics and Health Policy.

[18]  G. Pruneri,et al.  Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential. , 2012, Neoplasia.

[19]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[20]  H. Nielsen,et al.  Syncytin immunoreactivity in colorectal cancer: potential prognostic impact. , 2009, Cancer letters.

[21]  Hisashi Sakamaki,et al.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. , 2009, JAMA.

[22]  T. Heidmann,et al.  Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins , 2007, Proceedings of the National Academy of Sciences.

[23]  M. Sitbon,et al.  Emergence of vertebrate retroviruses and envelope capture. , 2004, Virology.

[24]  T. Heidmann,et al.  Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Depil,et al.  Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients , 2002, Leukemia.

[26]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[27]  G. Jackson,et al.  The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation , 2000, Leukemia.

[28]  J. Mccoy,et al.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis , 2000, Nature.

[29]  R. Kurth,et al.  Genome-Wide Screening, Cloning, Chromosomal Assignment, and Expression of Full-Length Human Endogenous Retrovirus Type K , 1999, Journal of Virology.

[30]  A. Andersson,et al.  Expression of the endogenous retrovirus ERV3 (HERV‐R) during induced monocytic differentiation in the U‐937 cell line , 1996, International journal of cancer.

[31]  R. Weiss,et al.  Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. , 1995, Virology.

[32]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[33]  K. Imakawa,et al.  The Phylogeny of Placental Evolution Through Dynamic Integrations of Retrotransposons. , 2017, Progress in molecular biology and translational science.

[34]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[35]  Kenji Nakamura,et al.  Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality , 2006, Nature Genetics.

[36]  L. Lin,et al.  The cellular mechanism by which the human endogenous retrovirus ERV-3 env gene affects proliferation and differentiation in a human placental trophoblast model, BeWo. , 2000, Placenta.